Images in HIV/AIDS. Fatal progressive multifocal leukoencephalopathy: still a problem in the era of highly active antiretroviral therapy
Cole, J.; Aboulafia, D.M.
Aids Reader 19(3): 110-112
2009
ISSN/ISBN: 1053-0894 PMID: 19334327 Document Number: 631425
Document emailed within 1 workday
Related Documents
Imamura, E.; Yamashita, H.; Fukuhara, T.; Sawa, H.; Nagashima, K.; Kuwabara, M.; Tokinobu, H. 2007: Case of highly active anti-retroviral therapy-induced immune reconstitution inflammatory syndrome in AIDS-related progressive multifocal leukoencephalopathy Rinsho Shinkeigaku 47(10): 650-656Ladizinski, B.; Heller, M.M.; Bhutani, T.; Zitelli, K.B.; Koo, J.Y.M. 2013: Progressive multifocal leukoencephalopathy and reversible progressive leukoencephalopathy syndrome in dermatologic therapy Journal of Drugs in Dermatology: Jdd 12(2): E20-E24
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Sulaiman, M.M.; Shettima, J.; Ummate, I.; Arogundade, F.A.; Yusuph, H.; Nwankwo, E.; Sanusi, A.A.; Akinsola, A. 2022: Comparative Evaluation of Prevalence, Risk Factors, and Pathologic Features of Kidney Disease in Highly Active Antiretroviral Therapy-Naive and Highly Active Antiretroviral Therapy-Experienced Patients at a Tertiary Health Facility in Maiduguri, Northeastern Nigeria Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia 33(1): 72-79
Mossakowski, M.J.; Zelman, I.B. 2000: Pathomorphological variations of the AIDS-associated progressive multifocal leukoencephalopathy Folia Neuropathologica 38(3): 91-100
Kuchelmeister, K.; Gullotta, F.; Bergmann, M.; Angeli, G.; Masini, T. 1991: Progressive multifocal leukoencephalopathy (PML) in AIDS: morphological and topographical characteristics Verhandlungen der Deutschen Gesellschaft für Pathologie 75: 189-190
Iranzo, D.; Romeu, J.; Castellote, E.; Coll, J. 1992: Gerstmann's syndrome and progressive multifocal leukoencephalopathy in a patient with AIDS Revista Clinica Espanola 191(7): 396-397
Rieder, C.R.M.; Ziomkowski, S.C. 2005: Head tremor and progressive multifocal leukoencephalopathy in AIDS patients: report of two cases Arquivos de Neuro-Psiquiatria 63(1): 150-153
Sarrazin, J.L.; Derosier, C.; Schill, H.; Neveux, Y.; Hor, F.; Cordoliani, Y.S. 1993: Progressive multifocal leukoencephalopathy localized in the thalamic grey matter in an AIDS-patient Journal de Radiologie 74(12): 645-648
Aström, K.E. 2001: Progressive multifocal leukoencephalopathy. Demyelinating viral disease--common complication of AIDS Lakartidningen 98(39): 4206
Gates, A.E.; Kaplan, L.D. 2002: AIDS malignancies in the era of highly active antiretroviral therapy Oncology 16(5): 657-665; Discussion 665: 668-670
Ramos, A.N.; Matida, L.H.; Hearst, N.; Heukelbach, J. 2011: Mortality in Brazilian children with HIV/AIDS: the role of non-AIDS-related conditions after highly active antiretroviral therapy introduction Aids Patient Care and Stds 25(12): 713-718
Nelwan, E.J. 2014: Adherence to highly active antiretroviral therapy (HAART) in HIV/AIDS patient Acta Medica Indonesiana 46(4): 273-274
Duran, A.C.F.L.; Almeida, L.B.; Segurado, A.A.C.; Jaime, P.C. 2008: Diet quality of persons living with HIV/AIDS on highly active antiretroviral therapy Journal of Human Nutrition and Dietetics: the Official Journal of the British Dietetic Association 21(4): 346-350
Bachur, T.Paschoalette.Rodrigues.; Vale, J.Martins.; Coêlho, I.Castelo.Branco.; Queiroz, T.Régia.Bezerra.Sales.de.; Chaves, C.de.Souza. 2008: Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(2): 115-122
Bachur, T.Paschoalette.Rodrigues.; Vale, J.Martins.; Coêlho, I.Castelo.Branco.; Queiroz, T.Régia.Bezerra.Sales.de.; Chaves, C.de.Souza. 2008: Enteric parasitic infections in HIV/AIDS patients before and after the highly active antiretroviral therapy Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 12(2): 115-122
Domingos, H.; Cunha, R.V.ân.d.; Paniago, A.M.M.; Martins, D.M.; Elkhoury, E.B.ão.; Souza, A.S.d. 2009: Metabolic effects associated to the highly active antiretroviral therapy (HAART) in AIDS patients Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 13(2): 130-136
Manfredi, R.; Calza, L. 2009: Malignancies not included among AIDS-defining disorders, in the era of highly active antiretroviral therapy Recenti Progressi in Medicina 100(12): 547-549
Kappers, M.H.W.; Swaak, A.J.G.; Zuidgeest, D.M.H.; Dees, A. 2006: Progressive multifocal leukoencephalopathy in a patient following long-term immunosuppressive therapy for systemic lupus erythematosus Nederlands Tijdschrift Voor Geneeskunde 150(7): 387-392